Published in Nat Med on November 10, 2014
Advancing biomedical imaging. Proc Natl Acad Sci U S A (2015) 0.91
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease? J Alzheimers Dis (2015) 0.83
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice. Alzheimers Res Ther (2015) 0.80
Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy. PLoS One (2015) 0.78
Impairments of neural circuit function in Alzheimer's disease. Philos Trans R Soc Lond B Biol Sci (2016) 0.78
Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET. Int J Mol Sci (2016) 0.77
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease. Cell Mol Neurobiol (2016) 0.77
Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers. J Cereb Blood Flow Metab (2015) 0.77
Towards Personalized Intervention for Alzheimer's Disease. Genomics Proteomics Bioinformatics (2016) 0.76
Multiparametric Imaging of Organ System Interfaces. Circ Cardiovasc Imaging (2017) 0.75
Quantitative multimodal multiparametric imaging in Alzheimer's disease. Brain Inform (2016) 0.75
Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation. Neurology (2016) 0.75
Functional Connectivity Mapping in the Animal Model: Principles and Applications of Resting-State fMRI. Front Neurol (2017) 0.75
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA (2015) 3.48
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. Lancet Neurol (2015) 0.96
Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases. J Nucl Med (2014) 0.89
Simultaneous PET/MRI in stroke: a case series. J Cereb Blood Flow Metab (2015) 0.85
Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans. J Nucl Med (2015) 0.83
Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging (2016) 0.83
Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging (2016) 0.82
New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget (2016) 0.81
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma. PLoS One (2016) 0.79
Quantification of β-Amyloidosis and rCBF with Dedicated PET, 7 T MR Imaging, and High-Resolution Microscopic MR Imaging at 16.4 T in APP23 Mice. J Nucl Med (2015) 0.76
Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model. Oncotarget (2016) 0.75
Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome. J Neuroimaging (2016) 0.75
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET. Eur J Nucl Med Mol Imaging (2017) 0.75
Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. J Alzheimers Dis (2015) 0.75
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry (2017) 0.75